122 related articles for article (PubMed ID: 26714724)
1. Measuring the Uptake and Transactivation Function of HIV-1 Tat Protein in a Trans-cellular Cocultivation Setup.
Ruiz AP; Prasad VR
Methods Mol Biol; 2016; 1354():353-66. PubMed ID: 26714724
[TBL] [Abstract][Full Text] [Related]
2. BK channels regulate extracellular Tat-mediated HIV-1 LTR transactivation.
Khan N; Lakpa KL; Halcrow PW; Afghah Z; Miller NM; Geiger JD; Chen X
Sci Rep; 2019 Aug; 9(1):12285. PubMed ID: 31439883
[TBL] [Abstract][Full Text] [Related]
3. Nrf2 is involved in inhibiting Tat-induced HIV-1 long terminal repeat transactivation.
Zhang HS; Li HY; Zhou Y; Wu MR; Zhou HS
Free Radic Biol Med; 2009 Aug; 47(3):261-8. PubMed ID: 19409485
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 Tat endocytosis and retention in endolysosomes affects HIV-1 Tat-induced LTR transactivation in astrocytes.
Khan N; Halcrow PW; Afghah Z; Baral A; Geiger JD; Chen X
FASEB J; 2022 Mar; 36(3):e22184. PubMed ID: 35113458
[TBL] [Abstract][Full Text] [Related]
5. An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently Tat-transfected cells and required for optimal HIV-1 LTR transactivating activity.
Zauli G; La Placa M; Vignoli M; Re MC; Gibellini D; Furlini G; Milani D; Marchisio M; Mazzoni M; Capitani S
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):306-16. PubMed ID: 7552492
[TBL] [Abstract][Full Text] [Related]
6. Endolysosome iron restricts Tat-mediated HIV-1 LTR transactivation by increasing HIV-1 Tat oligomerization and β-catenin expression.
Khan N; Halcrow PW; Lakpa LK; Rehan M; Chen X; Geiger JD
J Neurovirol; 2021 Oct; 27(5):755-773. PubMed ID: 34550543
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of transcriptional transactivation and restriction of human immunodeficiency virus type I replication in an astrocytic glial cell.
Niikura M; Dornadula G; Zhang H; Mukhtar M; Lingxun D; Khalili K; Bagasra O; Pomerantz RJ
Oncogene; 1996 Jul; 13(2):313-22. PubMed ID: 8710370
[TBL] [Abstract][Full Text] [Related]
8. The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells.
Forlani G; Turrini F; Ghezzi S; Tedeschi A; Poli G; Accolla RS; Tosi G
J Transl Med; 2016 Apr; 14():94. PubMed ID: 27089879
[TBL] [Abstract][Full Text] [Related]
9. Interaction of the phospholipid scramblase 1 with HIV-1 Tat results in the repression of Tat-dependent transcription.
Kusano S; Eizuru Y
Biochem Biophys Res Commun; 2013 Apr; 433(4):438-44. PubMed ID: 23501106
[TBL] [Abstract][Full Text] [Related]
10. Paracrine activation of the HIV-1 LTR promoter by the viral Tat protein is mechanistically similar to trans-activation within a cell.
Verhoef K; Klein A; Berkhout B
Virology; 1996 Nov; 225(2):316-27. PubMed ID: 8918918
[TBL] [Abstract][Full Text] [Related]
11. Tanshinone II A inhibits tat-induced HIV-1 transactivation through redox-regulated AMPK/Nampt pathway.
Zhang HS; Chen XY; Wu TC; Zhang FJ
J Cell Physiol; 2014 Sep; 229(9):1193-201. PubMed ID: 24414799
[TBL] [Abstract][Full Text] [Related]
12. Short communication: a single step assay for rapid evaluation of inhibitors targeting HIV type 1 Tat-mediated long terminal repeat transactivation.
Chande AG; Baba M; Mukhopadhyaya R
AIDS Res Hum Retroviruses; 2012 Aug; 28(8):902-6. PubMed ID: 21878060
[TBL] [Abstract][Full Text] [Related]
13. A Naturally Occurring Polymorphism in the HIV-1 Tat Basic Domain Inhibits Uptake by Bystander Cells and Leads to Reduced Neuroinflammation.
Ruiz AP; Ajasin DO; Ramasamy S; DesMarais V; Eugenin EA; Prasad VR
Sci Rep; 2019 Mar; 9(1):3308. PubMed ID: 30824746
[TBL] [Abstract][Full Text] [Related]
14. USP7 deubiquitinase controls HIV-1 production by stabilizing Tat protein.
Ali A; Raja R; Farooqui SR; Ahmad S; Banerjea AC
Biochem J; 2017 May; 474(10):1653-1668. PubMed ID: 28280111
[TBL] [Abstract][Full Text] [Related]
15. EGCG inhibits Tat-induced LTR transactivation: role of Nrf2, AKT, AMPK signaling pathway.
Zhang HS; Wu TC; Sang WW; Ruan Z
Life Sci; 2012 May; 90(19-20):747-54. PubMed ID: 22480519
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of intra- and extra-cellular Tat function and HIV expression by pertussis toxin B-oligomer.
Rizzi C; Alfano M; Bugatti A; Camozzi M; Poli G; Rusnati M
Eur J Immunol; 2004 Feb; 34(2):530-6. PubMed ID: 14768058
[TBL] [Abstract][Full Text] [Related]
17. Exosome-associated release, uptake, and neurotoxicity of HIV-1 Tat protein.
Rahimian P; He JJ
J Neurovirol; 2016 Dec; 22(6):774-788. PubMed ID: 27173397
[TBL] [Abstract][Full Text] [Related]
18. [Study of transactivation effect on transcription by Tat-TAR-system of human immunodeficiency virus type 1 (HIV-1) in non-lymphoid cells HEK293 and Calu-1].
Mingaleeva RN; Chernov IP; Kopantsev EP; Stukacheva EA; Skaptsova NV; Sverdlov ED
Mol Gen Mikrobiol Virusol; 2009; (2):11-5. PubMed ID: 19517804
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs.
Kashanchi F; Sadaie MR; Brady JN
Virology; 1997 Jan; 227(2):431-8. PubMed ID: 9018142
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus type 1 Tat activity in human neuronal cells: uptake and trans-activation.
Kolson DL; Collman R; Hrin R; Balliet JW; Laughlin M; McGann KA; Debouck C; Gonzalez-Scarano F
J Gen Virol; 1994 Aug; 75 ( Pt 8)():1927-34. PubMed ID: 8046394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]